Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction TPF and Concurrent Docetaxel/Cetuximab/IMRT in Recurrent NPC
NCT01326559Phase 2Completed
- Start
- Jun 2010
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in nasopharyngeal carcinoma (NPC). Started Jun 2010; status: completed.
02
Drugs
KL-140
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01326559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01326559.